AU2001265933A1 - Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds - Google Patents

Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds

Info

Publication number
AU2001265933A1
AU2001265933A1 AU2001265933A AU2001265933A AU2001265933A1 AU 2001265933 A1 AU2001265933 A1 AU 2001265933A1 AU 2001265933 A AU2001265933 A AU 2001265933A AU 2001265933 A AU2001265933 A AU 2001265933A AU 2001265933 A1 AU2001265933 A1 AU 2001265933A1
Authority
AU
Australia
Prior art keywords
compounds
pharmaceutical compositions
compositions containing
sulphonamide group
sulphonamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001265933A
Other versions
AU2001265933B2 (en
Inventor
Walter Elger
Annemarie Hedden
Alexander Hillisch
Klaus Schoellkopf
Sigfrid Schwarz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Bayer Schering Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10027887A external-priority patent/DE10027887A1/en
Application filed by Bayer Schering Pharma AG filed Critical Bayer Schering Pharma AG
Publication of AU2001265933A1 publication Critical patent/AU2001265933A1/en
Application granted granted Critical
Publication of AU2001265933B2 publication Critical patent/AU2001265933B2/en
Assigned to BAYER SCHERING PHARMA AKTIENGESELLSHAFT reassignment BAYER SCHERING PHARMA AKTIENGESELLSHAFT Alteration of Name(s) of Applicant(s) under S113 Assignors: SCHERING AKTIENGESELLSHAFT
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001265933A 2000-05-31 2001-05-08 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds Ceased AU2001265933B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10027887A DE10027887A1 (en) 2000-05-31 2000-05-31 Compounds with a sulfonamide group and pharmaceutical compositions containing these compounds
DE10027887 2000-05-31
PCT/EP2001/005169 WO2001091797A2 (en) 2000-05-31 2001-05-08 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds

Publications (2)

Publication Number Publication Date
AU2001265933A1 true AU2001265933A1 (en) 2002-02-28
AU2001265933B2 AU2001265933B2 (en) 2007-10-18

Family

ID=7644802

Family Applications (2)

Application Number Title Priority Date Filing Date
AU6593301A Pending AU6593301A (en) 2000-05-31 2001-05-08 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds
AU2001265933A Ceased AU2001265933B2 (en) 2000-05-31 2001-05-08 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU6593301A Pending AU6593301A (en) 2000-05-31 2001-05-08 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds

Country Status (29)

Country Link
US (2) US7507725B2 (en)
EP (1) EP1294402B2 (en)
JP (1) JP2003534386A (en)
KR (3) KR20080038460A (en)
CN (1) CN1441678A (en)
AT (1) ATE315407T1 (en)
AU (2) AU6593301A (en)
BG (1) BG107556A (en)
BR (1) BR0111294A (en)
CA (1) CA2410630A1 (en)
CZ (1) CZ2003621A3 (en)
DE (2) DE10027887A1 (en)
DK (1) DK1294402T4 (en)
EA (1) EA006432B1 (en)
ES (1) ES2256256T5 (en)
HR (1) HRP20021038B1 (en)
HU (1) HUP0301949A3 (en)
IL (2) IL152932A0 (en)
ME (1) MEP14608A (en)
MX (1) MXPA02011844A (en)
NO (1) NO20025739D0 (en)
NZ (1) NZ535201A (en)
PL (1) PL206462B1 (en)
PT (1) PT1294402E (en)
SK (1) SK2912003A3 (en)
UA (1) UA76953C2 (en)
WO (1) WO2001091797A2 (en)
YU (1) YU90102A (en)
ZA (1) ZA200209490B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (en) * 2000-05-31 2001-12-13 Jenapharm Gmbh Compounds with a sulfonamide group and pharmaceutical compositions containing these compounds
US8026229B2 (en) * 2001-08-13 2011-09-27 Sterix Limited Antitumor-active 2-alkoxyestradiol sulfamates
US20050282793A1 (en) * 2004-05-21 2005-12-22 Ralf Wyrwa Steroid prodrugs with androgenic action
US7534780B2 (en) * 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
DE102004025985A1 (en) * 2004-05-21 2005-12-15 Schering Ag Estriol and estetrol prodrugs
DE102004025986A1 (en) * 2004-05-21 2005-12-15 Schering Ag Steroid prodrugs with androgenic effects
DE102004025966A1 (en) * 2004-05-21 2005-12-15 Schering Ag Estradiol prodrugs
US20050277625A1 (en) * 2004-05-21 2005-12-15 Ralf Wyrwa Estriol and estetrol prodrugs
DE102005057225A1 (en) * 2005-11-29 2007-05-31 Bayer Schering Pharma Ag New 8-beta-substituted estratriene derivatives esterified with a sulfamoylphenyl-substituted acid residue, are prodrugs useful as carboanhydrase inhibitors for treating estrogen deficiency disorders
US20070197488A1 (en) * 2005-11-29 2007-08-23 Olaf Peters Prodrugs of ERbeta-selective substances, process for their production, and pharmaceutical compositions that contain these compounds
DE102005057224A1 (en) 2005-11-29 2007-05-31 Bayer Schering Pharma Ag New 9-alpha substituted estratriene derivatives esterified with a sulfamoylphenyl-substituted acid residue, are prodrugs useful as carboanhydrase inhibitors for treating estrogen deficiency disorders
US20070123500A1 (en) * 2005-11-29 2007-05-31 Gerd Mueller Prodrugs of ERbeta-selective substances, processes for their preparation and pharmaceutical compositions comprising these compounds
US20070135375A1 (en) * 2005-11-30 2007-06-14 Ralf Wyrwa Sulfamoyl sulfonate prodrugs
DE102005057421A1 (en) * 2005-11-30 2007-05-31 Bayer Schering Pharma Ag New heteroaromatic sulfonamide prodrugs, useful for delivering e.g. antimalarials and steroids for e.g. fertility control or hormone replacement therapy
US20070135399A1 (en) * 2005-11-30 2007-06-14 Ralf Wyrwa Heteroaromatic sulphonamide prodrugs
DE102005057408A1 (en) * 2005-11-30 2007-05-31 Bayer Schering Pharma Ag New sulfamoylsulfonate prodrugs e.g. useful for protecting red blood cells from attack by parasites or for hormone replacement therapy, female fertility control or treating hormone-associated diseases
US8777182B2 (en) 2008-05-20 2014-07-15 Grinon Industries Fluid transfer assembly and methods of fluid transfer
NZ589747A (en) 2008-05-20 2012-04-27 Grinon Ind Fluid container with a magnetic coupling device at the bottom
US9100458B2 (en) * 2008-09-11 2015-08-04 At&T Intellectual Property I, L.P. Apparatus and method for delivering media content
CN101987104A (en) * 2009-08-05 2011-03-23 天津金耀集团有限公司 Ophthalmic composition of heteroaryl sulfamoyl carboxylic ester carbonic anhydrase inhibitor
CN101987102A (en) * 2009-08-05 2011-03-23 天津金耀集团有限公司 Ophthalmic anti-inflammatory composition of glucocorticoid heteroaryl sulfamoyl carboxylate
CZ307182B6 (en) 2011-12-30 2018-02-28 Grinon Industries Fluid transfer assembly and methods of fluid transfer
PE20160655A1 (en) * 2013-07-11 2016-07-08 Evestra Inc COMPOUND FORMATION PROFARMACS
EP3173113A1 (en) * 2015-11-27 2017-05-31 Sanofi-Aventis Deutschland GmbH An injection needle assembly
DK3380149T3 (en) 2015-11-27 2020-02-03 Sanofi Aventis Deutschland PHARMACEUTICAL ADMINISTRATION WITH A CAP
US10624903B2 (en) 2017-10-19 2020-04-21 Evestra, Inc. Longer-acting progestin prodrug contraceptives

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1203042B (en) 1963-11-21 1965-10-14 Schering Ag Fungicides
GB1593609A (en) 1978-01-31 1981-07-22 Christiaens Sa A Pyridine sulfonamides
US4244940A (en) * 1978-09-05 1981-01-13 Bio-Rad Laboratories, Inc. Single-incubation two-site immunoassay
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
GB8327256D0 (en) * 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
US5001234A (en) † 1987-04-16 1991-03-19 The Upjohn Company Cyclic hydrocarbons with an aminoalkyl sidechain
US4792569A (en) * 1987-08-27 1988-12-20 Mcneilab, Inc. Anticonvulsant phenethyl sulfamates
US5116828A (en) 1989-10-26 1992-05-26 Nippon Zoki Pharmaceutical Co., Ltd. Pharmaceutical composition for treatment of osteoporosis
US5025031A (en) * 1989-11-30 1991-06-18 A. H. Robins Co., Inc. Aryl and aryloxyalkyl sulfamate esters useful as anticonvulsants
GB9118478D0 (en) 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
DE4236237A1 (en) 1992-10-27 1994-04-28 Behringwerke Ag Prodrugs, their preparation and use as medicines
US5384327A (en) 1992-12-22 1995-01-24 Mcneilab, Inc. Anticonvulsant sorbopyranose sulfamates
IL109431A (en) * 1993-05-14 2001-01-11 Warner Lambert Co Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds
DE4429398C2 (en) 1994-08-09 1997-09-11 Jenapharm Gmbh Use of Estra-1,3,5 (10) -triene derivatives for hormonal contraception
DE4429397C2 (en) * 1994-08-09 2003-11-20 Jenapharm Gmbh Estra-1,3,5 (10) -triene derivatives, processes for their preparation and pharmaceutical compositions containing these compounds
US5571933A (en) 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
US5705495A (en) * 1995-10-19 1998-01-06 Jenapharm Gmbh & Co. Kg. Sulfamate derivatives of 1,3,5(10)-estratriene derivatives, methods for their production and pharmaceuticals containing these compounds
DE19540233B4 (en) * 1995-10-19 2005-08-25 Schering Ag Sulfamate derivatives of 1,3,5 (10) estratriene derivatives, process for their preparation and pharmaceutical compositions containing them
DE19712488A1 (en) † 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroid sulfamates, processes for their preparation and use thereof
DE19723794A1 (en) * 1997-06-06 1998-12-10 Jenapharm Gmbh Non-estrogenic derivatives of estradiol with antioxidant activity
EP1100736A1 (en) * 1998-07-29 2001-05-23 Crisplant A/S Parcel singulation system
US6583130B1 (en) 1999-09-13 2003-06-24 Schering Ag C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, methods of preparing same, and pharmaceutical compositions containing these compounds
US6958327B1 (en) * 1999-11-02 2005-10-25 Schering, Ag 18 Norsteroids as selectively active estrogens
SK10022002A3 (en) 2000-01-14 2002-12-03 Sterix Limited Pharmaceutical compositions containing steroidal structures and uses thereof
SK14632002A3 (en) 2000-04-12 2003-03-04 Schering Aktiengesellschaft 8Beta-hydrocarbyl-substituted estratrienes for use as selective estrogens
DE10027887A1 (en) 2000-05-31 2001-12-13 Jenapharm Gmbh Compounds with a sulfonamide group and pharmaceutical compositions containing these compounds
US6355666B1 (en) 2000-06-23 2002-03-12 Medinox, Inc. Protected forms of pharmacologically active agents and uses therefor
JP2005511475A (en) 2001-03-02 2005-04-28 ブリストル−マイヤーズ スクイブ カンパニー Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions containing the same
WO2002076464A1 (en) * 2001-03-22 2002-10-03 Arena Pharmaceuticals, Inc. Anti-psychosis combination
US6956031B2 (en) 2002-03-27 2005-10-18 Schering Aktiengesellschaft 11β-Substituted 19-nor-17-α-pregna-1,3,5(10)-trien-17β-ols with a 21,16α-lactone ring
DE10226326A1 (en) 2002-06-11 2004-01-15 Schering Ag 9-alpha-substituted estratrienes as selective estrogens
US7414043B2 (en) 2002-06-11 2008-08-19 Schering Ag 9-α-substituted estratrienes as selectively active estrogens
EP1689410B1 (en) 2003-11-26 2008-05-21 Bayer Schering Pharma Aktiengesellschaft Prevention and treatment of hypertensive heart diseases by the selective estrogens 8beta-vinyl-estra-1,3,5(10)-trien-3,17beta-diol and 17beta-fluor-9alpha-vinyl-estra-1,3,5(10)-trien-3,16alpha-diol
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
US20050277625A1 (en) 2004-05-21 2005-12-15 Ralf Wyrwa Estriol and estetrol prodrugs
DE102004025966A1 (en) 2004-05-21 2005-12-15 Schering Ag Estradiol prodrugs
DE102004025986A1 (en) 2004-05-21 2005-12-15 Schering Ag Steroid prodrugs with androgenic effects
DE102004025985A1 (en) 2004-05-21 2005-12-15 Schering Ag Estriol and estetrol prodrugs
AR053845A1 (en) 2005-04-15 2007-05-23 Tibotec Pharm Ltd 5-TIAZOLILMETIL [(1S, 2R) -3 - [[(2-AMINO-6-BENZOXAZOLIL) SULFONIL)] (2-METHYLPROPIL) AMINO] -2-HYDROXY-1- (PHENYLMETIL) PROPIL] CARBAMATE AS A PHARMACY IMPROVER METABOLIZED BY THE CYCROCHROME P450

Similar Documents

Publication Publication Date Title
AU2001265933A1 (en) Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds
HUP0301949A3 (en) Compounds with a sulfonamide group and pharmaceutical compositions containing these compounds
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001274307A1 (en) Pharmaceutical compositions
AU2001292582A1 (en) C-nitroso compounds and use thereof
AU2001274579A1 (en) Resist composition
AU2002218751A1 (en) Stable radiopharmaceutical compositions
AU2002217464A1 (en) Medicinal compositions containing aspirin
AU2001295657A1 (en) Formulation containing wax-esters
AU3192700A (en) Medicinal compositions
AU2001292185A1 (en) Formulation containing amoxicillin
AU3556400A (en) Pharmaceutical compositions
AU2005300A (en) Medicinal compositions
AU2002214324A1 (en) Medicinal compositions
AU2001290239A1 (en) Medicinal composition
AU2792700A (en) Pharmaceutical composition containing cyclosporin
AU6460400A (en) Pharmaceutical compositions
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU6460200A (en) Pharmaceutical compositions
AU2001274535A1 (en) Hydroxyformamidine derivatives and medicines containing the same
AU2002246659A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU4884701A (en) Malonanilic acid derivatives, medicinal compositions containing the same and usethereof
AU6460300A (en) Pharmaceutical compositions
AU6460100A (en) Pharmaceutical compositions